Related Experiment Video
Updated: Oct 4, 2026

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis
Published on: February 16, 2015
Apoptosis regulators and their role in tumorigenesis
Abstract:
It has become clear that, together with deregulated growth, inhibition of programmed cell death (PCD) plays a pivotal role in tumorigenesis. In this review, we present an overview of the genes and mechanisms involved in PCD. We then summarize the evidence that impaired PCD is a prerequisite for tumorigenesis, as indicated by the fact that more and more neoplastic mutations appear to act by interfering with PCD. This has made the idea of restoration of corrupted 'death programs' an intriguing new area for potential cancer therapy.
Insights
Inhibition of programmed cell death (PCD) is crucial for cancer development. Restoring these natural cell death processes offers a promising new avenue for cancer therapy.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Programmed cell death (PCD) is a critical biological process that eliminates unwanted or damaged cells.
- Dysregulation of PCD is increasingly recognized as a significant factor in the development and progression of cancer.
- Many cancer-promoting mutations target and disrupt the molecular pathways governing PCD.
Purpose of the Study:
- To review the genes and molecular mechanisms underlying programmed cell death (PCD).
- To summarize the evidence linking impaired PCD to tumorigenesis.
- To explore the therapeutic potential of restoring defective PCD pathways in cancer treatment.
Main Methods:
- Literature review of genes and mechanisms involved in PCD.
- Analysis of evidence supporting the role of impaired PCD in cancer.
- Discussion of therapeutic strategies targeting PCD.
Main Results:
- Programmed cell death (PCD) is a fundamental process that, when inhibited, contributes significantly to cancer.
- Numerous genetic mutations found in tumors directly interfere with PCD pathways.
- Evidence strongly suggests that defective PCD is a necessary step for cancer to arise.
Conclusions:
- Inhibition of programmed cell death (PCD) is a key hallmark of cancer.
- Understanding the molecular basis of PCD is essential for cancer research.
- Targeting and restoring 'death programs' represents a novel and promising strategy for cancer therapy.
Related Concept Videos
Apoptosis
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Negative Regulator Molecules
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

